Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature

Ashley L.B. Raghu, Jason A. Chen, Pablo A. Valdes, Walid Ibn Essayed, Elizabeth Claus, Omar Arnaout, Timothy R. Smith, E. Antonio Chiocca, Pier Paolo Peruzzi, Joshua D. Bernstock

Research output: Contribution to journalReview articlepeer-review

Abstract

World Health Organization (WHO) grade 4 gliomas of the cerebellum are rare entities whose understanding trails that of their supratentorial counterparts. Like supratentorial high-grade gliomas (sHGG), cerebellar high-grade gliomas (cHGG) preferentially affect males and prognosis is bleak; however, they are more common in a younger population. While current therapy for cerebellar and supratentorial HGG is the same, recent molecular analyses have identified features and subclasses of cerebellar tumors that may merit individualized targeting. One recent series of cHGG included the subclasses of (1) high-grade astrocytoma with piloid features (HGAP, ~31% of tumors); (2) H3K27M diffuse midline glioma (~8%); and (3) isocitrate dehydrogenase (IDH) wildtype glioblastoma (~43%). The latter had an unusually low-frequency of epidermal growth factor receptor (EGFR) and high-frequency of platelet-derived growth factor receptor alpha (PDGFRA) amplification, reflecting a different composition of methylation classes compared to supratentorial IDH-wildtype tumors. These new classifications have begun to reveal insights into the pathogenesis of HGG in the cerebellum and lead toward individualized treatment targeted toward the appropriate subclass of cHGG. Emerging therapeutic strategies include targeting the mitogen-activated protein kinases (MAPK) pathway and PDGFRA, oncolytic virotherapy, and immunotherapy. HGGs of the cerebellum exhibit biological differences compared to sHGG, and improved understanding of their molecular subclasses has the potential to advance treatment.

Original languageEnglish (US)
Article number174
JournalCancers
Volume15
Issue number1
DOIs
StatePublished - Jan 2023

Keywords

  • cerebellum
  • experimental therapeutics
  • glioblastoma (GBM)
  • high-grade glioma (HGG)
  • immunotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Cerebellar High-Grade Glioma: A Translationally Oriented Review of the Literature'. Together they form a unique fingerprint.

Cite this